2 years ago
ASRT
AnalystsThomas FlatenThomas Flaten's Stock Forecasts
AnalystsThomas Flaten
Analyst Ranking
Top 27%
#1333 out of 5071 analysts
Average Return
+7.14%
Win Rate
41%18 out of 44
Risk vs Reward
Poor
Good
Thomas Flaten's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Diamedica Therapeutics IncDMAC | +220.63% | $1.26 | $4.04 | 2022-07-06 - 2023-07-06 | Strong Buy |
Aquestive Therapeutics IncAQST | +165.66% | $2.65 | $7.04 | 2025-03-07 - 2025-10-21 | Strong Buy |
Personalis IncPSNL | +158.50% | $1.47 | $3.80 | 2024-04-29 - 2025-04-29 | Strong Buy |
Biolife Solutions IncBLFS | +152.95% | $15.77 | $39.89 | 2020-02-23 - 2021-02-24 | Strong Buy |
Insight Molecular Diagnostics IncIMDX | +115.96% | $3.07 | $6.63 | 2025-05-20 - 2025-10-21 | Strong Buy |
Thomas Flaten Analyst Color
Get additional color on Thomas Flaten's coverage of popular stocks
Thomas Flaten's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Evaxion AEVAX | 3 | Strong Buy | $11.00 | +68.45% | Maintains | 3 days ago |
Harrow IncHROW | 1 | Strong Buy | $70.00 | +71.48% | Maintains | 24 days ago |
Journey Medical CorpDERM | 2 | Strong Buy | $13.00 | +76.87% | Maintains | 2 months ago |
Rapid Micro Biosystems IncRPID | 1 | Strong Buy | $8.00 | +173.04% | Initiates Coverage On | 3 months ago |
Diamedica Therapeutics IncDMAC | 2 | Strong Buy | $14.00 | +111.48% | Maintains | 3 months ago |
Aytu Biopharma IncAYTU | 1 | Strong Buy | $8.00 | +238.98% | Initiates Coverage On | 4 months ago |
Insight Molecular Diagnostics IncIMDX | 5 | Strong Buy | $8.00 | +20.66% | Maintains | 5 months ago |
Biodesix IncBDSX | 1 | Strong Buy | $40.00 | +485.65% | Maintains | 5 months ago |
Castle Biosciences IncCSTL | 6 | Strong Buy | $35.00 | +49.57% | Maintains | 6 months ago |
Optinose IncOPTN | 4 | Hold | $9.00 | -6.25% | Downgrades | 7 months ago |
Checkpoint Therapeutics IncCKPT | 5 | Hold | $4.10 | -3.76% | Downgrades | 7 months ago |
Aquestive Therapeutics IncAQST | 2 | Strong Buy | $8.00 | +13.64% | Maintains | 8 months ago |
Personalis IncPSNL | 2 | Strong Buy | $9.00 | -5.96% | Maintains | 9 months ago |
Dermtech IncDMTKQ | 1 | Hold | $0.63 | N/A | Downgrades | 2 years ago |
Assertio Holdings IncASRT | 3 | Strong Buy | $3.00 | N/A | Maintains | 2 years ago |
Achieve Life Sciences IncACHV | 3 | Strong Buy | $11.00 | N/A | Maintains | 2 years ago |
Better Therapeutics IncBTTX | 2 | Strong Buy | $3.00 | N/A | Maintains | 2 years ago |
Biolife Solutions IncBLFS | 2 | Strong Buy | $25.00 | N/A | Maintains | 2 years ago |
Fresh Tracks Therapeutics IncFRTX | 2 | Hold | N/A | N/A | Downgrades | 3 years ago |
Ensysce Biosciences IncENSC | 1 | Strong Buy | $14,400.00 | N/A | Initiates Coverage On | 4 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.